|
Market Closed -
OTC Markets
11:13:09 2026-04-02 EDT
|
5-day change | 1st Jan Change | ||
| 82.75 USD | +4.81% |
|
-.--% | +1.78% |
| 08-27 | Orion launches share buyback for incentive program | FW |
| 08-10 | Orion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial | MT |
Company Valuation: Orion Oyj
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 5,119 | 7,179 | 5,509 | 6,005 | 8,944 | 11,232 | - | - |
| Change | - | 40.25% | -23.26% | 8.99% | 48.95% | 25.58% | - | - |
| Enterprise Value (EV) 1 | 5,010 | 7,060 | 5,603 | 6,126 | 9,088 | 11,142 | 10,899 | 10,629 |
| Change | - | 40.91% | -20.65% | 9.35% | 48.35% | 22.59% | -2.18% | -2.48% |
| P/E | 26.5x | 20.6x | 25.5x | 18.2x | 17.9x | 19.8x | 16.8x | 15.1x |
| PBR | 6.86x | 7.91x | 6.19x | 5.98x | 6.97x | 7x | 5.64x | 4.62x |
| PEG | - | 0.3x | -0.7x | 0.3x | 0.3x | 1.5x | 0.9x | 1.3x |
| Capitalization / Revenue | 4.92x | 5.36x | 4.63x | 3.89x | 4.73x | 5.35x | 4.73x | 4.39x |
| EV / Revenue | 4.81x | 5.27x | 4.71x | 3.97x | 4.81x | 5.31x | 4.59x | 4.16x |
| EV / EBITDA | 17.3x | 14.5x | 17.2x | 12x | 13.2x | 14.4x | 12x | 10.6x |
| EV / EBIT | 20.6x | 16.1x | 20.4x | 14.7x | 14.4x | 15.7x | 13x | 11.4x |
| EV / FCF | 38.5x | 21.7x | 105x | 29.7x | 41.5x | 22.6x | 21.1x | 16.9x |
| FCF Yield | 2.6% | 4.6% | 0.95% | 3.37% | 2.41% | 4.42% | 4.73% | 5.91% |
| Dividend per Share 2 | 1.5 | 1.6 | 1.62 | 1.64 | 1.8 | 1.945 | 2.168 | 2.47 |
| Rate of return | 4.11% | 3.12% | 4.13% | 3.83% | 2.83% | 2.44% | 2.72% | 3.1% |
| EPS 2 | 1.38 | 2.49 | 1.54 | 2.35 | 3.56 | 4.022 | 4.746 | 5.298 |
| Distribution rate | 109% | 64.3% | 105% | 69.8% | 50.6% | 48.4% | 45.7% | 46.6% |
| Net sales 1 | 1,041 | 1,341 | 1,190 | 1,542 | 1,890 | 2,098 | 2,374 | 2,557 |
| EBITDA 1 | 289.1 | 487.1 | 326.4 | 509.4 | 688.3 | 772.6 | 906.7 | 1,002 |
| EBIT 1 | 243.3 | 439.6 | 274.9 | 416.6 | 631.6 | 709.6 | 837.6 | 933.2 |
| Net income 1 | 193.8 | 349.5 | 216.8 | 329.9 | 500.3 | 565.9 | 667.9 | 746.2 |
| Net Debt 1 | -108.3 | -118.7 | 93.3 | 121.7 | 144.4 | -89.76 | -333 | -603.1 |
| Reference price 2 | 36.52 | 51.24 | 39.27 | 42.78 | 63.65 | 79.80 | 79.80 | 79.80 |
| Nbr of stocks (in thousands) | 140,563 | 140,202 | 140,351 | 140,501 | 140,693 | 140,866 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/13/24 | 2/25/25 | 2/12/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 32.72x | 11.9x | 24.26x | 0.6% | 1,024B | |
| 30.62x | - | - | 1.95% | 663B | |
| 32.73x | 7.6x | 15.8x | 2.67% | 453B | |
| 19.89x | 4.73x | 11.71x | 2.8% | 352B | |
| 22.72x | 5.84x | 14.51x | 2.7% | 304B | |
| 20.87x | 4.29x | 12.24x | 2.06% | 252B | |
| 27.66x | 7.14x | 13.15x | 2.31% | 236B | |
| 13.33x | 4.82x | 10.06x | 3.78% | 206B | |
| -46.14x | 6.65x | 25.95x | 2.18% | 187B | |
| Average | 17.16x | 6.62x | 15.96x | 2.34% | 408.71B | |
| Weighted average by Cap. | 24.05x | 7.99x | 17.80x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ORNBV Stock
- ORINF Stock
- Valuation Orion Oyj
Select your edition
All financial news and data tailored to specific country editions
